[
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors",
    "summary": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=233610cce0204ca52ff80247b2819b88d82d5224152abb783fb86fe47f30908b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747932600,
      "headline": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors",
      "id": 134670921,
      "image": "",
      "related": "EW",
      "source": "MarketWatch",
      "summary": "Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=233610cce0204ca52ff80247b2819b88d82d5224152abb783fb86fe47f30908b"
    }
  },
  {
    "ts": null,
    "headline": "Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick",
    "summary": "Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.",
    "url": "https://finnhub.io/api/news?id=f367481207584d49340341a3052e8f87f4523229e0d37c06f6ab31c482af7014",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747919881,
      "headline": "Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick",
      "id": 134659008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "EW",
      "source": "Yahoo",
      "summary": "Investing.com -- Citi analysts revised their MedTech coverage following a volatile first quarter, with several rating changes and adjustments to target prices.",
      "url": "https://finnhub.io/api/news?id=f367481207584d49340341a3052e8f87f4523229e0d37c06f6ab31c482af7014"
    }
  },
  {
    "ts": null,
    "headline": "Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes",
    "summary": "Edwards Lifesciences announced new economic and clinical evidence on severe aortic stenosis presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of...",
    "url": "https://finnhub.io/api/news?id=d38f2dff0440eae4476dbeabc2a098cbbe7084837175af56ade74b369a898730",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747900286,
      "headline": "Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes",
      "id": 134647742,
      "image": "",
      "related": "EW",
      "source": "Finnhub",
      "summary": "Edwards Lifesciences announced new economic and clinical evidence on severe aortic stenosis presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of...",
      "url": "https://finnhub.io/api/news?id=d38f2dff0440eae4476dbeabc2a098cbbe7084837175af56ade74b369a898730"
    }
  }
]